Free Guide to Medicare Immunotherapy Treatment Coverage
What Immunotherapy Is and How It Works Immunotherapy is a type of cancer treatment that helps your body's own immune system fight cancer cells. Unlike tradit...
What Immunotherapy Is and How It Works
Immunotherapy is a type of cancer treatment that helps your body's own immune system fight cancer cells. Unlike traditional chemotherapy, which uses strong chemicals to kill cancer cells throughout the body, immunotherapy works by boosting your immune system or teaching it to recognize and attack cancer more effectively.
Your immune system normally protects you from infections and disease by identifying harmful invaders. Cancer cells are tricky because they can hide from your immune system or turn off its warning signals. Immunotherapy drugs work in several ways to fix this problem. Some drugs block the "off switches" that cancer cells use to hide. Others mark cancer cells so your immune system can spot them more easily. A third type of immunotherapy actually strengthens your immune cells to make them better fighters.
There are several main types of immunotherapy drugs. Checkpoint inhibitors are among the most common. They remove the brakes that cancer puts on your immune system. Monoclonal antibodies are lab-made proteins that target specific cancer cells or immune cells. CAR-T cell therapy involves taking your own immune cells, modifying them in a laboratory to better attack cancer, and putting them back into your body. Cytokine therapy uses proteins that signal your immune cells to work harder. Cancer vaccines teach your immune system to recognize and fight cancer cells.
Immunotherapy has shown real results for many types of cancer, including melanoma, lung cancer, kidney cancer, and blood cancers. The National Cancer Institute reports that some immunotherapy drugs have extended survival times for certain cancer patients by months or even years. However, immunotherapy does not work the same way for everyone, and it may work better for some cancer types than others.
Practical takeaway: Understanding how immunotherapy works helps you make informed conversations with your doctor about whether it might be right for your situation. Ask your oncologist which type of immunotherapy they're considering and why they think it may help your specific cancer.
Medicare Coverage for Immunotherapy Drugs
Medicare is a federal health insurance program that covers people age 65 and older, some younger people with disabilities, and people with end-stage renal disease. Medicare Part B covers outpatient cancer treatments, including most immunotherapy drugs given in a hospital or clinic setting. Medicare Part D covers some oral immunotherapy medications that you take at home.
Medicare covers many immunotherapy drugs that the Food and Drug Administration (FDA) has approved for cancer treatment. This includes checkpoint inhibitors like pembrolizumab (Keytruda), nivolumab (Opdivo), and atezolizumab (Tecentriq). It also covers monoclonal antibodies like trastuzumab (Herceptin) and rituximab (Rituxan). The specific immunotherapy drugs that Medicare covers depend on the type of cancer you have and whether the FDA has approved that drug for your particular cancer.
When you receive immunotherapy as an outpatient through Medicare Part B, you typically pay 20% of the approved amount after you meet your Part B deductible. Medicare pays the remaining 80%. If you receive immunotherapy as an inpatient in a hospital, your costs work differently. You pay a one-time deductible per hospital stay, and Medicare covers the rest for up to 60 days. Some people choose to purchase supplemental insurance (Medigap) or join a Medicare Advantage plan to help cover the 20% out-of-pocket costs.
The cost of immunotherapy drugs is very high. Some immunotherapy medications can cost $100,000 to $150,000 or more per year. This is why understanding your Medicare coverage is so important. Even though you only pay 20% under Part B, that 20% can still be thousands of dollars per treatment. Many drug manufacturers offer patient assistance programs that may help reduce your out-of-pocket costs. These programs may cover copays, coinsurance, or deductibles for people who meet certain income requirements.
Practical takeaway: Contact your cancer center's financial counselor or social worker to understand your exact out-of-pocket costs for the specific immunotherapy your doctor recommends. Ask about manufacturer assistance programs and whether you might benefit from a Medigap policy or Medicare Advantage plan.
How to Find Information About Your Specific Cancer and Treatment Options
Different types of cancer respond differently to immunotherapy. Some cancers have high response rates to immunotherapy, while others have lower rates. Your cancer type, stage, and specific mutations all affect whether immunotherapy may be a treatment option for you. Learning about what treatments are used for your particular cancer helps you have better conversations with your medical team.
The National Cancer Institute (NCI) maintains a database called Cancer.gov where you can search for information specific to your cancer type. You can find out what treatments are standard for your cancer, what clinical trials are happening, and what survival statistics look like. The American Cancer Society also provides detailed guides for different cancer types, including information about immunotherapy options.
Your oncologist is your best source for personalized information. They can tell you whether immunotherapy is recommended for your specific cancer based on its stage, location, and genetic markers. Some cancers have specific genetic mutations—like PD-L1 expression or microsatellite instability—that predict whether immunotherapy will work better. Your doctor can discuss the results of your tumor testing and what they mean for treatment choices.
Many academic medical centers publish treatment guidelines that show which immunotherapy drugs are recommended for different cancers. The National Comprehensive Cancer Network (NCCN) publishes free guidelines for healthcare providers that you can also read. These guidelines change as new research comes out, so they represent current medical thinking about which treatments work best.
Patient advocacy organizations specific to your cancer type often have resources about immunotherapy. Organizations like the American Lung Cancer Association, Melanoma Research Foundation, or Kidney Cancer Association provide information written for patients. These organizations often have support groups where you can talk with others who have had similar cancer diagnoses and treatment experiences.
Practical takeaway: Ask your oncology team about your cancer's specific characteristics and which immunotherapy drugs they consider most likely to help. Write down the names of your cancer type, stage, and any genetic markers. Use this information to research your cancer through Cancer.gov and disease-specific organizations.
Understanding Medicare Part B and Part D Coverage Details
Medicare Part B is hospital insurance that covers treatments received outside the hospital, including outpatient cancer care. When you receive immunotherapy at a hospital outpatient center or clinic, Medicare Part B typically covers it. Your share of the cost is 20% of the Medicare-approved amount, after you meet your annual deductible. In 2024, the Part B deductible is $240. Once you reach that amount in out-of-pocket costs, Medicare covers 80% of additional services for the rest of the year.
Medicare Part D provides prescription drug coverage. This part of Medicare covers medications you take at home, including oral immunotherapy drugs. Part D plans vary significantly—different plans cover different drugs and charge different copays. If your immunotherapy is an oral medication, you need to check whether your specific Part D plan covers it and what your copay or coinsurance will be. Some oral immunotherapy drugs are very expensive, and Part D plans may require you to pay more out-of-pocket than Part B would for an injection.
Many immunotherapy drugs are considered specialty medications because of their high cost and complexity. Part D specialty drugs may have higher copays than regular medications. Some Part D plans place these drugs on higher cost-sharing tiers, meaning you pay a larger percentage of the drug's cost. For example, one plan might charge 25% coinsurance while another charges 33%. These differences can amount to hundreds or thousands of dollars per month.
Medicare also has a program called the Extra Help Program (Low-Income Subsidy) that assists people with limited income and resources in paying Part D costs. If your income is below certain levels, you may pay significantly less for prescriptions. The income limits vary by state, but in 2024, the federal poverty level for one person is about $14,580 per year. You can contact your local Social Security office or visit Medicare.gov to see if you qualify for Extra Help.
Some states also have programs that help pay Medicare costs for people with limited income. These are called Medicaid programs or State Pharmaceutical Assistance Programs. The rules vary significantly by state. Contact your state Medicaid office to learn what programs your state offers.
Practical takeaway: Compare your current Part D plan's coverage of your immunotherapy drug to other available plans during the
Related Guides
More guides on the way
Browse our full collection of free guides on topics that matter.
Browse All Guides →